Scilex Holding (NASDAQ:SCLXW – Get Free Report)’s share price shot up 22% during trading on Wednesday . The company traded as high as $0.11 and last traded at $0.11. 369 shares were traded during trading, a decline of 96% from the average session volume of 9,118 shares. The stock had previously closed at $0.09.
Scilex Stock Performance
The business has a 50 day moving average of $0.21 and a 200 day moving average of $0.26.
Scilex Company Profile
Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
Further Reading
- Five stocks we like better than Scilex
- Are Penny Stocks a Good Fit for Your Portfolio?
- Buffett’s on the Sidelines – Should You Follow?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- The How And Why of Investing in Oil Stocks
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Scilex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scilex and related companies with MarketBeat.com's FREE daily email newsletter.
